Announcement
·
06 May 2025
·
M42 appoints Dimitris Moulavasilis as Group CEO

Harnessing the Power of Proteomic

31 January 2024
Specialized Medical Fields

About the Speakers

  • Albarah El Khani
    Senior Director of Operations at M42
  • Dr. Sara Suliman
    Consultant Endocrinologist and Diabetologist for Imperial College London
  • Dr. Tiago Magalhaes
    Director of Bioinformatics for M42
  • Dr. Shalini Behl
    R&D Scientist, Omics Centre of Excellence for M42
  • Dr. Nicolas Sirotin
    Former Chair, Preventative Medicine, and Consultant International Medicine for Cleveland Clinic Abu Dhabi

    Watch Next